Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

Share Price is delayed by 15 minutes
Get Live Data
1.45    0.05 (3.45%)
Bid:
1.40
Ask:
1.50
Spread: 0.10 (7.143%)
Market Cap: £12.93m
XSG Live PriceLast checked at - London Stock Exchange

Intraday Xeros Tech Share Chart

Trading Update

5 Sep 2024 07:00

RNS Number : 9574C
Xeros Technology Group plc
05 September 2024
 

This announcement contains inside information as stipulated under the market abuse regulation no. 596/2014 (as incorporated into UK law by virtue of the European Union (Withdrawal) Act 2018, as amended by virtue of the Market Abuse (Amendment) (EU Exit) Regulations 2019). Upon the publication of this announcement via a regulatory information service, this inside information is now considered to be in the public domain.

 

5 September 2024

Xeros Technology Group plc

("Xeros", the "Company" or the "Group")

 

Trading Update

Xeros Technology Group plc (AIM: XSG), the creator of technologies that reduce the impact of clothing on the planet, announces the following trading update, ahead of its Half Yearly Results, which will be published later this month.

 

In a circular to shareholders, published on 8 April 2024, the Group reported that its Indian domestic laundry licensee, IFB Industries Limited ("IFB"), was conducting field trials on a 9kg washing machine, ahead of a planned mass market launch in 2024, delivering first royalty revenues to Xeros in FY24. While it is pleasing to note that the trials generated positive consumer feedback, IFB has initiated a further change to the specification of the 9kg machine, in no way related to Xeros technology, with the Board now expecting the mass market launch to take place in 2025. This situation has been compounded by the recent announcement of a change in leadership in the Home Appliances Division of IFB.

 

In the same circular, mentioned above, we referred to upcoming French legislation for microfibre filtration in washing machines. The environmental impact of microplastics is well established and the need for filtration in both commercial and domestic washing machines continues to be discussed globally. France was expected to lead the way with legislation, effective 1 January 2025, detailing clear standards and efficacies for new filtration technologies and driving early adoption.

 

Today, while the filtration legislation is in place in France, the standards and efficacies pertaining to it remain unclarified. As a result, this is not expected to drive demand for the Group's XF3 technology in the short term, as the Board anticipated earlier in the year. The Board is, however, confident that the market for microfibre filtration in washing machines remains significant in the medium term and that the licensing agreements it has in place, including the one with Donlim announced separately today, leave the Group well placed to generate significant revenues from this developing market.

 

Financial outlook

 

The impact of these delays is to reduce the Group's revenue expectations for FY24 and FY25 to £0.5m and £3.8m respectively, and adjusted EBITDA loss to £4.2m for FY24 and £1.0m for FY25. The Group anticipates cash balances at 31 December 2024 of £2.9m. The Group maintains tight control on costs (SG&A running at 60% of 2022 levels) and expects to reduce selling, general and administrative costs further in 2025.

 

Cash at 30 August 2024 was £4.0m, which the Board still expects to be sufficient to finance operations through to month on month cashflow break-even, during the latter part of 2025.

 

Commercial progress

 

While the Board is disappointed by these delays and their impact on the Group's short term financials, the medium term outlook for the company continues to strengthen.

 

The management team is progressing a number of new licensing agreements with tier 1 global OEMs, in relation the Group's Care and Filtration technology. These include three global OEMs, which are in active processes with regards to its Domestic Care technology, and one global OEM, with regards to Commercial Care technology. The Board expects to be able to communicate the outcome of these discussions in the coming months.

 

Furthermore, the Group's newest licensee for its Finish technology, KRM Tekstil/Yilmak Makina ("Yilmak"), launched a Xeros enabled range of denim finishing machines at ITM, a leading garment finishing trade show, in July 2024. Yilmak is working through the initial sales leads, with the expectation of machines being in full production within the current calendar year. The company is a tier 1 OEM within the global garment finishing market and represents a meaningful revenue opportunity for the Group. Revenue generation for Xeros from this licensing agreement remains on track to commence in the current financial year.

 

Enquiries

 

Xeros Technology Group plc

Neil Austin, Chief Executive Officer

Alex Tristram, Finance Director

 

Tel: 0114 269 9656

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Julian Blunt/Teddy Whiley, Corporate Finance

Andrew Burdis/Sunila de Silva, ECM

 

Tel: 020 7220 0500

Rawlings Financial PR Limited

Cat Valentine

Tel: 07715 769078

cat@rfpr.co.uk

 

About Xeros

 

Xeros Technology plc has developed patented and proven, industry-leading technologies which reduce the environmental impact of how industries make and care for clothes.

 

The traditional wet processing methods used in industrial and domestic laundry and garment manufacturing consume billions of litres of fresh water and large amounts of energy and chemicals, as well as damaging and weakening clothing fibres and creating rising levels of environmental pollution. It is estimated that washing machines contribute 35% of the 171 trillion microplastic particles in the ocean.

 

A range of actors, including consumers, the media NGOs and regulators are exerting pressure on these industries, with legislative action beginning to be taken.

 

Xeros' three main technologies, FiltrationFinish, and Care, facilitate garment manufacturers, industrial laundries, domestic washing machine manufacturers and consumers, to reduce their environmental impact, whilst also significantly improving efficiency in the process.

 

Xeros' model is to generate revenue from licensing its technologies, generating royalties and the sale of consumables. Currently there are eight agreements in place. The addressable markets in Filtration, Finish and Care are estimated to be valued at £350m p.a., £132m p.a. and £3bn p.a. respectively.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKQBQABKDACK
Date   Source Headline
28th Apr 20267:00 amRNSFull Year Results 2025
21st Apr 20267:00 amRNSNotice of Results and Online Presentation
5th Mar 20267:00 amRNSPurchase Order ahead of European Launch of XF3
11th Feb 202610:39 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSBoard Change
27th Jan 20267:00 amRNSTrading Update
7th Jan 20262:52 pmRNSTR-1 First Equity
2nd Jan 202611:46 amRNSBlock listing Interim Review
11th Dec 20251:06 pmRNSTR-1 Entrepreneurs Fund
2nd Dec 20254:48 pmRNSTR-1 Lombard Odier
2nd Dec 20252:26 pmRNSTR-1 Dowgate
2nd Dec 202511:10 amRNSTR-1 Maven
28th Nov 202511:02 amRNSResults of General Meeting and Director Dealings
27th Nov 202512:28 pmRNSResult of Follow-on Subscription and TVR
26th Nov 20254:44 pmRNSTR-1 Spreadex
11th Nov 20251:14 pmRNSResult of Retail Offer
7th Nov 202510:15 amRNSResult of Fundraising
7th Nov 20257:00 amRNSRetail Offer
6th Nov 20256:32 pmRNSProposed Fundraise
24th Oct 20253:07 pmRNSBlock listing Interim Review
14th Oct 20255:11 pmRNSTR-1 Maven
10th Oct 20255:20 pmRNSTR-1 Dowgate
9th Oct 20252:05 pmRNSTR-1 Spreadex
9th Oct 202511:04 amRNSTR-1 First Equity
8th Oct 20257:00 amRNSBreakthrough Launch Agreement
1st Oct 20252:08 pmRNS-RInterim Results 2025 Online Presentation
30th Sep 20257:00 amRNSInterim Results 2025
15th Sep 20256:07 pmRNSTR-1 Dowgate
12th Sep 20251:03 pmRNSTR-1 Dowgate
5th Aug 202512:13 pmRNSTR-1 First Equity
7th Jul 20252:33 pmRNSTR-1 Spreadex
19th Jun 20251:46 pmRNSResult of AGM
5th Jun 202510:11 amRNSCorrection - Application for Block Listing
4th Jun 202510:00 amRNSApplication for Block Listing
29th May 20252:43 pmRNSTR-1 Spreadex
28th May 20253:32 pmRNSTR-1 First Equity
28th May 20252:31 pmRNSTR-1 Spreadex
27th May 20252:37 pmRNSNotice of AGM and Posting of Annual Report
20th May 20257:00 amRNSFull Year Results 2024 and Trading Update
9th May 202511:08 amRNSTR-1 Spreadex
7th May 20257:00 amRNSNotice of Results and Online Presentation
6th May 202510:10 amRNSTR-1 Maven Capital
2nd May 20254:00 pmRNSTR-1 Spreadex
1st May 20254:35 pmRNSTR-1 - First Equity
31st Mar 20257:00 amRNSGrant of Options
7th Mar 202512:56 pmRNSTR-1 Spreadex
17th Feb 20252:18 pmRNSTR-1 Spreadex
17th Feb 202511:07 amRNSTR-1 First Equity
13th Feb 202512:05 pmRNSTR-1 Spreadex
13th Feb 202510:21 amRNSTR-1 First Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.